[1]
J. Wang, “Application Status and Practical Analysis of Surrogate Endpoints in Clinical Trial Design for Orphan Drugs”, IJPHMR, vol. 6, no. 6, pp. 14–20, Jun. 2026, doi: 10.62051/ijphmr.v6n6.03.